Literature DB >> 16532289

Staining the anterior capsule with indocyanine green or trypan blue for capsulorhexis in eyes with white cataract.

Yang Xiao1, Yu-hong Wang, Zhi-yong Fu, Hui Hong.   

Abstract

AIM: To assess the efficacy and safety of indocyanine green (ICG) 0.5% and trypan blue 0.1% for anterior capsule staining in cases of white cataract.
METHODS: This prospective study comprised 55 eyes of 55 patients with white cataract that had phacoemulsification with foldable intraocular lens implantation. ICG in 30 eyes and trypan blue in 25 eyes were used under air to stain the anterior lens capsule. The staining patterns and the ease of creating a continuous curvilinear capsulorhexis (CCC) were assessed; the intraoperative and postoperative complications were noted. The mean follow-up was 17.68+/-1.65 months. RESULT: Either ICG or trypan blue stained the anterior capsule uniformly. However, the staining provided by trypan blue was slightly superior. A CCC was successfully achieved in 25 eyes (100%) with trypan blue, and 29 eyes (96.7%) with ICG, respectively. There was no significant postoperative reaction in any eye.
CONCLUSION: The use of vital dyes such as ICG and trypan blue guarantees a complete CCC and makes it possible to deliver the benefits of phacoemulsification in the patients with white cataract.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16532289     DOI: 10.1007/s10792-005-2228-4

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  7 in total

1.  Corneal endothelial cell density after trypan blue capsule staining in cataract surgery.

Authors:  Bart T H van Dooren; Peter W T de Waard; Hester Poort-van Nouhuys; W Houdijn Beekhuis; Gerrit R J Melles
Journal:  J Cataract Refract Surg       Date:  2002-04       Impact factor: 3.351

2.  Inadvertent staining of the vitreous with trypan blue.

Authors:  Prakash Kumar Chowdhury; Shetal M Raj; Abhay R Vasavada
Journal:  J Cataract Refract Surg       Date:  2004-01       Impact factor: 3.351

3.  Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes.

Authors:  M Veckeneer; K van Overdam; J Monzer; K Kobuch; W van Marle; H Spekreijse; J van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-09       Impact factor: 3.117

4.  Effect of indocyanine green intraocular stain on human and rabbit corneal endothelial structure and viability. An in vitro study.

Authors:  Glenn P Holley; Abu Alam; Aantariksha Kiri; Henry F Edelhauser
Journal:  J Cataract Refract Surg       Date:  2002-06       Impact factor: 3.351

5.  An epidemiologic survey of senile cataract in China.

Authors:  W S Mao; T S Hu
Journal:  Chin Med J (Engl)       Date:  1982-11       Impact factor: 2.628

6.  Trypan blue as an adjunct for safe phacoemulsification in eyes with white cataract.

Authors:  Soosan Jacob; Amar Agarwal; Athiya Agarwal; Sunita Agarwal; Saurabh Chowdhary; Reena Chowdhary; Anand A Bagmar
Journal:  J Cataract Refract Surg       Date:  2002-10       Impact factor: 3.351

7.  Permanent blue discoloration of a hydrogel intraocular lens by intraoperative trypan blue.

Authors:  Liliana Werner; David J Apple; Armando S Crema; Andrea M Izak; Suresh K Pandey; Rupal H Trivedi; Liwei Ma
Journal:  J Cataract Refract Surg       Date:  2002-07       Impact factor: 3.351

  7 in total
  3 in total

1.  Impact of Indocyanine Green Concentration, Exposure Time, and Degree of Dissolution in Creating Toxic Anterior Segment Syndrome: Evaluation in a Rabbit Model.

Authors:  Tamer Tandogan; Ramin Khoramnia; Gerd Uwe Auffarth; Michael Janusz Koss; Chul Young Choi
Journal:  J Ophthalmol       Date:  2016-07-12       Impact factor: 1.909

2.  Central corneal thickness changes following manual small incision cataract surgery versus phacoemulsification for white cataract.

Authors:  Pipat Kongsap
Journal:  Rom J Ophthalmol       Date:  2019 Jan-Mar

3.  Mini-rhexis for white intumescent cataracts.

Authors:  Newton Kara-Junior; Marcony Rodrigues de Santhiago; Andrea Kawakami; Pedro Carricondo; Wilson Takashi Hida
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.